Compare IRTC & BXMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRTC | BXMT |
|---|---|---|
| Founded | 2006 | 1966 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 3.1B |
| IPO Year | 2016 | N/A |
| Metric | IRTC | BXMT |
|---|---|---|
| Price | $169.94 | $20.47 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 14 | 5 |
| Target Price | ★ $203.93 | $20.25 |
| AVG Volume (30 Days) | 479.0K | ★ 1.2M |
| Earning Date | 10-30-2025 | 10-29-2025 |
| Dividend Yield | N/A | ★ 9.19% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.62 |
| Revenue | ★ $702,573,000.00 | $393,335,000.00 |
| Revenue This Year | $27.20 | N/A |
| Revenue Next Year | $16.89 | $10.51 |
| P/E Ratio | ★ N/A | $32.87 |
| Revenue Growth | ★ 25.45 | N/A |
| 52 Week Low | $84.17 | $16.51 |
| 52 Week High | $212.00 | $21.24 |
| Indicator | IRTC | BXMT |
|---|---|---|
| Relative Strength Index (RSI) | 38.34 | 73.62 |
| Support Level | $166.76 | $19.55 |
| Resistance Level | $187.98 | $19.95 |
| Average True Range (ATR) | 6.55 | 0.32 |
| MACD | -1.41 | 0.12 |
| Stochastic Oscillator | 9.08 | 91.28 |
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
Blackstone Mortgage Trust Inc is a real estate finance company involved in the origination and purchase of senior loans collateralized by commercial properties in North America, Europe, and Australia. The vast majority of the company's asset portfolio is comprised of floating rate loans secured by priority mortgages. These mortgages are mainly derived from office, hotel, and manufactured housing properties. A percentage of the collateralized real estate properties are located in New York, California, and the United Kingdom. Blackstone Mortgage Trust is managed by a subsidiary of The Blackstone Group and benefits from the market data provided by its parent company. Nearly all of Blackstone Mortgage Trust's revenue is generated in the form of interest income.